Affichem Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Affichem General Information

Description

Developer of therapeutic molecules and theranostic markers designed to develop and commercialize innovative therapeutic molecules. The company eases the treatment of cancer and neurodegenerative diseases through its developed molecules in the field of cancer and neurodegenerative diseases, development, and commercialization of products for the pharmaceutical industry, helping patients with the treatment of cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 9 Saint-joseph Street
  • 31400 Toulouse
  • France
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
HealthTech, Oncology
Corporate Office
  • 9 Saint-joseph Street
  • 31400 Toulouse
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Affichem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Dec-2022 Completed Generating Revenue
4. Grant 29-Jun-2012 Completed Generating Revenue
3. Grant 07-Oct-2011 Completed Generating Revenue
2. Angel (individual) 17-Nov-2009 $89.3K $159K Completed Startup
1. Accelerator/Incubator 01-Jun-2002 $70.1K $70.1K Completed Startup
To view Affichem’s complete valuation and funding history, request access »

Affichem Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Affichem’s complete cap table history, request access »

Affichem Patents

Affichem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200016177-A1 Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof Inactive 22-Sep-2016
US-20230138400-A1 Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof Pending 22-Sep-2016
EP-3097904-A1 Depigmenting agents to lighten the skin Active 29-May-2015
EP-3097904-B1 Depigmenting agents to lighten the skin Active 29-May-2015
EP-3221467-A1 Methods of diagnosing cancer and of predicting response of cancer to dendrogenin a treatment Inactive 17-Nov-2014 C12Q1/6886
To view Affichem’s complete patent history, request access »

Affichem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Affichem Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Commission Government
L'Agence Nationale de la Recherche Government
To view Affichem’s complete investors history, request access »

Affichem FAQs

  • When was Affichem founded?

    Affichem was founded in 2002.

  • Where is Affichem headquartered?

    Affichem is headquartered in Toulouse, France.

  • What is the size of Affichem?

    Affichem has 9 total employees.

  • What industry is Affichem in?

    Affichem’s primary industry is Biotechnology.

  • Is Affichem a private or public company?

    Affichem is a Private company.

  • What is Affichem’s current revenue?

    The current revenue for Affichem is .

  • How much funding has Affichem raised over time?

    Affichem has raised $159K.

  • Who are Affichem’s investors?

    European Commission and L'Agence Nationale de la Recherche have invested in Affichem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »